BICALIEVA 50mg Tablet: Targeted Non-Steroidal Anti-Androgen Therapy for Prostate Cancer Management Are you searching for a reliable BICALIEVA 500 mg Tablet exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of targeted endocrine therapies. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical oncology medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is BICALIEVA 50 mg? BICALIEVA 50 mg is an oral targeted therapy containing the active pharmaceutical ingredient Bicalutamide. Manufactured by Allieva Pharma Pvt Ltd, this 50mg tablet belongs to the class of medications known as Non-Steroidal Anti-Androgens. It is specifically designed to treat advanced prostate cancer by neutralizing the effects of male hormones (androgens) that stimulate the growth of malignant cells. 1. Therapeutic Indications Advanced Prostate Cancer: Used in combination therapy with a Luteinizing Hormone-Releasing Hormone (LHRH) analog (like Leuprolide or Goserelin). Metastatic Disease: Effective in managing Stage D2 metastatic carcinoma of the prostate. Hormone-Sensitive Prostate Cancer: Often utilized as part of a “Combined Androgen Blockade“ (CAB) to maximize treatment efficacy. Flaring Prevention: Administered at the start of LHRH agonist therapy to prevent the “testosterone flare“ that can temporarily worsen symptoms. 2. Mechanism of Action: Androgen Receptor Inhibition Receptor Blocking: It competitively binds to the cytosol androgen receptors in the target tissue (the prostate gland). Signal Interruption: By occupying these receptors, it prevents Dihydrotestosterone (DHT) and Testosterone from binding to the cancer cells. Tumor Suppression: Without the “fuel“ provided by androgens, the growth of prostate cancer cells is inhibited, and the tumor may shrink or stabilize. 3. Administration and Dosage Management Standard Dosing: The typical recommended dose is one 50mg tablet taken once daily. Administration: Can be taken with or without food. Tablets should be swallowed whole at the same time each day. Combination Timing: When used with an LHRH agonist, treatment with Bicalieva should be started at the same time as the injection to ensure maximum hormonal control. Clinical Side Effects & Safety Monitoring Hepatotoxicity: Rare but serious liver injury can occur; Liver Function Tests (LFTs) should be performed regularly. Gynecomastia: Breast tenderness or enlargement is a common side effect due to hormonal shifts. Vasomotor Symptoms: Potential for hot flashes and generalized weakness or fatigue. Glucose Tolerance: Patients with diabetes should monitor blood sugar levels, as anti-androgens can affect insulin sensitivity. Why Source BICALIEVA 50mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva Pharma’s BICALIEVA with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex import/export regulations for USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us
